Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Radiation Dose Hypofractionation × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Prostatic Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Carcinoma, Intraductal, Noninfiltrating 2 Urinary Bladder Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Prostate Adenocarcinoma 1 Pituitary Neoplasms 1 Pancreatic Neoplasms 1 Neurilemmoma 1 Nerve Sheath Neoplasms 1 Meningioma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Carcinoma In Situ 1 Brain Neoplasms 1 Advanced Refractory Solid Tumors 1

Interventions

Bevacizumab 24 atezolizumab 19 durvalumab 18 Specimen Handling 15 pembrolizumab 12 lenvatinib 11 Magnetic Resonance Spectroscopy 11 tremelimumab 10 Nivolumab 10 Sorafenib 8 Radiosurgery 8 Cyclophosphamide 6 camrelizumab 5 apatinib 5 Ipilimumab 5 tislelizumab 4 regorafenib 4 fludarabine 4 cabozantinib 4 X-Rays 4 Immunoglobulin G 4 sintilimab 3 gadolinium ethoxybenzyl DTPA 3 Immune Checkpoint Inhibitors 3 Ethiodized Oil 3 E-7386 3 Disulfides 3 Blood Specimen Collection 3 Biopsy 3 gadobutrol 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡